跳至主要内容
临床试验/NCT07762599
NCT07762599尚未招募不适用

Evaluation of Effect of Silver Nanoparticles Reinforced Double Antibiotic Paste on Inflammatory Biomarkers , Post Endodontic Pain and Periapical Healing in Teeth With Symptomatic Apical Periodontitis :a Parallel, Double-blind, Randomized Controlled Trial.

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年8月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
1
主要终点
Change in gingival crevicular fluid IL-1 beta and MMP-9 levels

研究概览

简要总结

Background Apical periodontitis (AP) is an inflammatory condition of the periapical tissues. The Symptomatic Apical periodontitis (SAP) represents the active phase of the disease, presenting with pain and tenderness. In SAP, levels of inflammatory mediators such as Interleukin-1β (IL-1β) and Matrix Metalloproteinase-9 (MMP-9) are elevated in gingival crevicular fluid (GCF). Assessing these biomarkers in GCF provides a novel, non-invasive method to evaluate periapical inflammation and healing. Due to the polymicrobial nature of root canal infections, the use of Intracanal medicaments (ICM) has been recommended to achieve effective disinfection. Traditionally used ICMs have their own inherent limitations. Hence, ICMs such as Triple antibiotic paste (TAP), double antibiotic paste (DAP), Silver nanoparticles (AgNPs) and their various combinations are gaining popularity. Currently, various combinations of AgNPs with other agents such as chitosan, calcium hydroxide, antibiotics and various herbal products are being tried to improve its effectiveness when used as an ICM. However, to the best of investigators knowledge, no study reinforced the DAP with AgNPs. Hence, the current double-blind, randomized, parallel clinical trial is planned to compare the effects of DAP with and without reinforcement of AgNPs on inflammatory biomarkers (IL-1β and MMP-9), postendodontic pain, and periapical healing in SAP. Moreover, this DAP+AgNPs formulation will undergo characterization such as FTIR, TEM/SEM, Zeta potential to assess its properties.

Methods A total of 50 adult participants with SAP in single-rooted teeth were randomly divided into two groups based on the type of ICM used: Group I received DAP, while Group II received DAP reinforced with AgNPs. Before starting the root canal treatment, GCF will be collected and marked as baseline. Then under rubber dam isolation all teeth underwent root canal treatment and ICM will be placed according to the specific group. Patient will be recalled after 14 days and again GCF sample will be collected after removal of the ICM. The samples will be stored at -800C for analysis. All samples will undergo enzyme-linked immunosorbent assay (ELISA) to estimate IL1β and MMP-9 levels. Pain levels will be recorded using the Numerical Rating scale (NRS) at various intervals. Data will be analyzed using STATA, SPSS or R. P value < 0.05 will be considered statistically significant.

Discussion Most conventional ICM have limited ability to penetrate where residual microorganisms often persist. Nanoparticle-based formulations such as AgNPs have gained attention because of their extremely small size, surface charge, and potent antimicrobial activity, which enable them to penetrate dentinal tubules and disrupt bacterial biofilms that are resistant to conventional antibiotics. Incorporating AgNPs into DAP could therefore enhance their antibacterial efficacy. Furthermore, since most endodontic pathogens cannot be routinely cultivated, monitoring the changes in inflammatory biomarkers in GCF provides a reliable and non-invasive method to assess the biological response and healing. Hence, the current double-blind, randomized, parallel clinical trial is planned to compare the effects of DAP with and without reinforcement of AgNPs on inflammatory biomarkers (IL-1β and MMP-9), postendodontic pain, and periapical healing in SAP. The findings may support the use of nanoparticle-assisted ICM as a safer and more effective approach for endodontic disinfection and healing

详细描述

Background and rationale Apical periodontitis (AP) is an inflammatory condition that arises from bacterial infection in the necrotic root canal system causing local inflammation of periapical tissues. The infected pulp is the primary cause of apical periodontitis, resulting in destruction of periapical tissues and bone resorption. AP can be symptomatic or asymptomatic.

Symptomatic apical periodontitis (SAP) presents with spontaneous pain, tenderness to percussion/palpation, and pain on mastication. Radiographic signs may be absent early, but inflammatory mediators like pro-inflammatory cytokines IL-1β, TNF-α, IL-6, IL-8, matrix metalloproteinases (MMP-2, MMP-8, MMP-9), and mediators such as prostaglandin E2 (PGE2), substance P, and calcitonin gene-related peptide are markedly elevated. These molecules collectively contribute to periapical tissue destruction, bone resorption, and pain perception, reflecting the active disease state and host inflammatory response. Quantifying levels of proinflammatory and anti-inflammatory cytokines involved in these immune processes holds promise as potential biomarkers to objectively assess the presence or absence of endodontic disease. Biomarkers used to assess endodontic pathology can be collected from various oral and dental sites, including the dental pulp, dentin, saliva, and gingival crevicular fluid (GCF).

The collection of GCF involves a simple, fast, and noninvasive procedure that can be completed chairside, making it a promising tool to improve diagnosis in endodontics. Inflammatory markers collected in GCF have been widely studied in recent decades IL-1β and MMP 9 significantly increased in Apical Periodontitis Moreover, the persistence of intracanal microorganisms and their by-products, even after thorough chemo-mechanical debridement, remains the primary reason for endodontic failure. Enterococcus faecalis is one of the most resistant organisms associated with persistent periapical infections due to its ability to penetrate dentinal tubules and form biofilms. Therefore ICM are essential adjuncts for disinfection between appointments in multi-visit endodontic therapy to eliminate the bacteria.

Calcium hydroxide has been the gold standard; however, it demonstrates limited activity against E. faecalis and other resistant species. Long-term use of calcium hydroxide can reduce the fracture resistance of the teeth. Antibiotics are valuable alternatives for the management of bacterial infections. During endodontic treatment antibiotics may be applied systemically or locally. Due to the ineffectiveness of systemic antibiotics in necrotic teeth, the local application of antibiotics is a more effective mode for delivery during root canal treatment.Considering the polymicrobial nature of tooth infection, single empirical antibiotics are not able to provide a bacteria-free zone in the canal. It is essential to use a combination of antibiotics against all endodontic pathogens to prevent microbial resistance. The most practical combination in order to reach a sufficient result is Triple Antibiotic Paste (TAP).

TAP containing metronidazole, ciprofloxacin and minocycline has been proposed as a root canal medicament due to its antimicrobial effects. It is more useful in reducing bacterial count than calcium hydroxide .However among the components of the mixture, minocycline can induce tooth discoloration even in low concentrations.To avoid discoloration caused by minocycline, a double antibiotic paste (DAP) made of only metronidazole, and ciprofloxacin has been proposed which showed equal effectiveness as that of TAP. DAP not only provided better antimicrobial effect but also helps in reduction in pain almost equal in efficacy to TAP Moreover residual antibacterial efficacy of DAP is longer than that of TAP. Acc to Afsaneh Rahmati et al. DAP also shows significantly better outcomes compared to calcium hydroxide as ICM in the treatment of teeth with Periapical lesions. DAP offer a more effective therapeutic approach in managing necrotic pulps and apical periodontitis, potentially improving patient outcomes and treatment success rates. American Association of Endodontists recommended the use of diluted antibiotics (TAP) in a concentration of 0.1-1 mg/ml. However bacteria remain viable in dentinal tubules of teeth with apical periodontitis and this relatively low concentrations of DAP may not be effective against established bacterial biofilm.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult participants (aged 18-60 years) with SAP and Periapical Pathology in single rooted teeth.
  • Preoperative pain score will be assessed and recorded using the NRS on a scale 0 to
  • Patients will be asked to mark their current pain level on the scale of 0-
  • Patients with pain level ≥7 will be included in the study (NRS categorized as none (0), mild (1-3), moderate (4-6), and severe (7-10).
  • Periapical pathology will be diagnosed according to PAI and patient with PAI ≥3 will be included in the study (PAI -Score 1 Normal periapical structure, Score2: Minor changes in bone structure, Score 3 Changes in bone structure with some mineral loss, Score4: A well-defined radiolucent area, Score 5 Severe periodontitis with exacerbated features)
  • Systemic Health will be assessed using ASA. Patient with ASA II will be included in the study.

排除标准

  • Previous endodontic treatment
  • Absence of antagonist tooth
  • Teeth with Immature apex
  • Severe periodontal disease or root resorption
  • Use of antibiotics within 1 month or analgesics within 3 days
  • Pregnancy or lactation.
  • Allergy to study medicaments

研究组 & 干预措施

silver nanoparticles reinforced double antibiotic paste

Experimental

In symptomatic apical periodontitis patients silver nanoparticles reinforced double antibiotic paste will placed as an intracanal medicament

干预措施: silver nanoparticles reinforced double antibiotic paste (Drug)

Standard double antibiotic paste

Active Comparator

In symptomatic apical periodontitis patients double antibiotic paste will placed as an intracanal medicament

干预措施: Double Antibiotic Paste (Drug)

结局指标

主要结局

Change in gingival crevicular fluid IL-1 beta and MMP-9 levels

时间窗: Baseline and 14 days post-treatment

IL-1 beta and MMP-9 levels will be measured in gingival crevicular fluid at baseline and after 14 days of intracanal medicament placement ,comparing DAP and DAP+ AgNPs group

Change in Post Endodontic Pain intensity

时间窗: Baseline and after 14 days post -treatment

Post Endodontic Pain will be assessed using Numerical Rating Scale (NRS) at 24 hr,48hr,72hr,7 days and 14 days following intracanal medicament placement comparing DAP and DAP+AgNPs group

次要结局

  • Radiographic Periapical Healing(3 months and 6 months post treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ganesh Jadhav

Associate Professor

All India Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验